AMSTERDAM and WASHINGTON, March 18, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) today announced that the results from two large clinical trials comparing patient outcomes using instant ...
Royal Philips (NYSE: PHG, AEX: PHIA) today announced that the results from two large clinical trials comparing patient outcomes using instant wave-free ratio (iFR) and fractional flow reserve (FFR) in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio WASHINGTON — At 1 year, rates of MACE in ...
Instantaneous wave-free ratio (iFR) may have a role to play in the acute setting of primary PCI, a new analysis suggests. Agreement between an acute iFR evaluation of nonculprit arteries and one ...
Both fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) measurements are strongly associated with adverse outcomes in patients with deferred lesions, but patients with discordant ...
Health economic data from the DEFINE FLAIR trial demonstrates an iFR-guided strategy reduces costs and improves patient comfort compared to an FFR-guided strategy, while delivering consistent cost ...
Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback